Lewati ke konten

Analisis Efektivitas Biaya dan kualitas hidup pasien hipertensi rawat inap di RSUD Massenrempulu Kabupaten Enrekang Periode Januari-Maret 2022

Saiful, Renaldi and Maulana, Andi and Purnamasari, Vina (2023) Analisis Efektivitas Biaya dan kualitas hidup pasien hipertensi rawat inap di RSUD Massenrempulu Kabupaten Enrekang Periode Januari-Maret 2022. Other thesis, Universitas Muslim Indonesia.

[thumbnail of Sampul - RENALDI SAIFUL.pdf] Text
Sampul - RENALDI SAIFUL.pdf

Download (48kB)
[thumbnail of Lembar Pengesahan - RENALDI SAIFUL.pdf] Text
Lembar Pengesahan - RENALDI SAIFUL.pdf

Download (297kB)
[thumbnail of Daftar Isi - RENALDI SAIFUL.pdf] Text
Daftar Isi - RENALDI SAIFUL.pdf

Download (79kB)
[thumbnail of Abstrak - RENALDI SAIFUL.pdf] Text
Abstrak - RENALDI SAIFUL.pdf

Download (68kB)
[thumbnail of BAB 1 - RENALDI SAIFUL.pdf] Text
BAB 1 - RENALDI SAIFUL.pdf

Download (279kB)
[thumbnail of BAB 5 - RENALDI SAIFUL.pdf] Text
BAB 5 - RENALDI SAIFUL.pdf

Download (59kB)
[thumbnail of DAFTAR PUSTAKA - RENALDI SAIFUL.pdf] Text
DAFTAR PUSTAKA - RENALDI SAIFUL.pdf

Download (178kB)
[thumbnail of LAMPIRAN - RENALDI SAIFUL.pdf] Text
LAMPIRAN - RENALDI SAIFUL.pdf

Download (1MB)

Abstract

Renaldi Saiful., 2023, Analisis Efektivitas Biaya dan Kualitas Hidup Pasien Hipertensi Rawat Inap di RSUD Massenrempulu Kabupaten Enrekang Periode Januari-Maret 2022 (Dibimbing oleh Andi Maulana K.P Lolo dan Vina Purnamasari)
Hipertensi merupakan salah satu penyakit kronik yang membutuhkan pengobtan jangka panjang dengan biaya yang tinggi. Pada penelitian ini bertujuan untuk mengetahui hasil analisis efektivitas biaya dan kualitas hidup pasien hipertensi rawat di RSUD Massenrempulu Kabupaten Enrekang periode Januari-Maret 2022. Penelitian ini bersifat observasional dengan pendekatan cross-sectional. Pengambilan sampel dilakukan dengan menggunakan Teknik consecutive sampling. Data sekunder diperoleh secara retrospektif dari data rekam medik dan biaya medis langsung pasien hipertensi. Kemduian dilakukan uji statistik pada data kualitas hidup. Dari hasil penelitian monoterapi antihipertensi yang hemat biaya yaitu monoterapi Irbesartan 150 mg dengan nilai ACER sebesar Rp.31.554,-. Sedangkan pada terapi kombinasi yang hemat biaya ditunjukan pada kombinasi Clonidine 0,15 mg & Irbesartan 300 mg dengan nilai ACER sebesar Rp.40.565,-. Kemudian pada kualitas hidup pasien terdapat perbedaan yang signifikan antara tekanan darah sebelum dan sesudah terapi. Dengan demikian pada kualitas hidup pasien hipertensi masuk kedalam kategori normal atau adanya penurunan tekanan darah setelah mendapatkan terapi antihipertensi selama perawatan di RSUD Massenrempulu Kabupaten Enrekang.
Kata Kunci: Farmakoekonomi, Hemat biaya, Kualitas hidup, Antihipertensi.

ABSTRACT
RENALDI SAIFUL. 2023. Analysis of Cost-Effectiveness and Life
Quality on Inpatient Hypertensive Patients at Massenrempulu Hospital,
Enrekang Regency from January to March 2022 (Supervised by Andi
Maulana K.P Lolo and Vina Purnamasari)
Hypertension is one of the chronic diseases that requires long-term
and costly treatment. This study aimed to determine the results of the costeffectiveness
analysis and quality of life of hospitalized hypertensive
patients at Massenrempulu Hospital, Enrekang Regency from January to
March 2022. This study conducted observational research with a crosssectional
approach. Sampling collection was carried out using consecutive
sampling techniques. Secondary data were obtained retrospectively from
medical record data and direct medical costs of hypertensive patients. Then,
the research performed statistical tests on life quality data. From the result,
it found a cost-effective antihypertensive monotherapy study, namely
Irbesartan monotherapy 150 mg with an ACER value of Rp.31,554. While
the cost-effective combination therapy was shown from the combination of
Clonidine 0.15 mg &; Irbesartan 300 mg with an ACER value of Rp.40,565.
Next, life quality of patients indicated a significant difference between blood
pressure before and after the test. Thus, the quality of life of hypertensive
patients was identified as the normal category or there was not a decrease
in blood pressure after receiving antihypertensive therapy during treatment
at Massenrempulu Hospital, Enrekang Regency.
Keywords: Pharmacoeconomics, Cost-effective, Quality of life,
Antihypertensive.

Item Type: Thesis (Other)
Subjects: R Medicine > R Medicine (General)
Divisions: FAKULTAS FARMASI
Depositing User: operator 10
Date Deposited: 10 Oct 2024 03:29
Last Modified: 10 Oct 2024 03:29
URI: http://192.168.168.84/id/eprint/7044

Actions (login required)

View Item View Item